Severe Haemophilia A With Inhibitors Clinical Trial
Official title:
Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients
This study aims to evaluate the immunomodulatory effect of FEIBA® in patients with severe haemophilia A and inhibitors.
This is an observational, multicentric, case-control and one-single-visit study of patients
with severe haemophilia A and inhibitors against FVIII in therapy with FEIBA®.
Two subject groups will be included: Group 1 (cases) will be composed of patients with
severe haemophilia A and inhibitors in prophylaxis with FEIBA®; Group 2 (controls) will be
composed of patients with severe haemophilia A and inhibitors on-demand treatment with
FEIBA®.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional